Literature DB >> 22854119

Chronic pain leads to concomitant noradrenergic impairment and mood disorders.

Cristina Alba-Delgado1, Meritxell Llorca-Torralba, Igor Horrillo, Jorge E Ortega, Juan Antonio Mico, Pilar Sánchez-Blázquez, J Javier Meana, Esther Berrocoso.   

Abstract

BACKGROUND: Patients suffering chronic pain are at high risk of suffering long-lasting emotional disturbances characterized by persistent low mood and anxiety. We propose that this might be the result of a functional impairment in noradrenergic circuits associated with locus coeruleus (LC) and prefrontal cortex, where emotional and sensorial pain processes overlap.
METHODS: We used a chronic constriction injury of sciatic nerve as a model of neuropathic pain in male Sprague-Dawley rats to assess the time-dependent changes that might potentially precipitate mood disorders (2, 7, 14, and 28 days after injury). This was measured through a combination of behavioral, electrophysiological, microdialysis, immunohistochemical, and Western blot assays.
RESULTS: As expected, nerve injury produced an early and stable decrease in sensorial pain threshold over the testing period. By contrast, long-term neuropathic pain (28 days after injury) resulted in an inability to cope with stressful situations, provoking depressive and anxiogenic-like behaviors, even more intense than the aversiveness associated with pain perception. The onset of these behavioral changes coincided with irruption of noradrenergic dysfunction, evident as: an increase in LC bursting activity; in tyrosine hydroxylase expression and that of the noradrenaline transporter; and enhanced expression and sensitivity of α2-adrenoceptors in the LC.
CONCLUSIONS: Long-term neuropathic pain leads to anxio-depressive-like behaviors that are more predominant than the aversion of a painful experience. These changes are consistent with the impairment of noradrenergic system described in depressive disorders.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854119     DOI: 10.1016/j.biopsych.2012.06.033

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

Review 1.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

2.  Blockade of α2-adrenergic or metabotropic glutamate receptors induces glutamate release in the locus coeruleus to activate descending inhibition in rats with chronic neuropathic hypersensitivity.

Authors:  Ken-Ichiro Hayashida; Masafumi Kimuram; James C Eisenach
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

3.  Nortriptyline Enhances Morphine-Conditioned Place Preference in Neuropathic Rats: Role of the Central Noradrenergic System.

Authors:  Wenli Mi; Shuxing Wang; Zerong You; Grewo Lim; Michael F McCabe; Hyangin Kim; Lucy Chen; Jianren Mao
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

4.  Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.

Authors:  Galen Missig; Linda Mei; Margaret A Vizzard; Karen M Braas; James A Waschek; Kerry J Ressler; Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2016-08-29       Impact factor: 13.382

5.  Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.

Authors:  Meritxell Llorca-Torralba; Fuencisla Pilar-Cuéllar; Lidia Bravo; Cristina Bruzos-Cidon; María Torrecilla; Juan A Mico; Luisa Ugedo; Emilio Garro-Martínez; Esther Berrocoso
Journal:  Mol Neurobiol       Date:  2018-10-03       Impact factor: 5.590

6.  Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs.

Authors:  L Perez-Caballero; R Pérez-Egea; C Romero-Grimaldi; D Puigdemont; J Molet; J-R Caso; J-A Mico; V Pérez; J-C Leza; E Berrocoso
Journal:  Mol Psychiatry       Date:  2013-05-28       Impact factor: 15.992

7.  Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.

Authors:  Xin Zhao; Chuang Wang; Jun-Fang Zhang; Li Liu; Ai-Ming Liu; Qing Ma; Wen-Hua Zhou; Ying Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

Review 8.  Modulation of pain, nociception, and analgesia by the brain reward center.

Authors:  Vasiliki Mitsi; Venetia Zachariou
Journal:  Neuroscience       Date:  2016-05-14       Impact factor: 3.590

9.  Gabapentin increases extracellular glutamatergic level in the locus coeruleus via astroglial glutamate transporter-dependent mechanisms.

Authors:  Takashi Suto; Amie L Severino; James C Eisenach; Ken-ichiro Hayashida
Journal:  Neuropharmacology       Date:  2014-02-01       Impact factor: 5.250

10.  Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity.

Authors:  Eugene L Dimitrov; Mumeko C Tsuda; Heather A Cameron; Ted B Usdin
Journal:  J Neurosci       Date:  2014-09-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.